Neurocrine halts development of schizophrenia drug as trial fails
페이지 정보
본문
Sept 12 (Reuters) - Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function in patients with schizophrenia, after it did not achieve the primary goal buy neurocaine powder in bulk usa a mid-stage trial.
The company said the drug, luvadaxistat, did not replicate the results from a previous mid-stage trial that showed improved cognitive performance, due to a large variability in the cognitive measures across the patients and a potential imbalance in their baseline characteristics.
In the previous study, luvadaxistat failed to meet the main goal of change from baseline in negative symptoms of schizophrenia, however, it met the secondary goal of improving cognitive performance.
If you have any inquiries pertaining to in which and how to use buy neurocaine powder in bulk usa, you can speak to us at our site. Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates.
Shares of the company were down 2.5% in extended trading.
Last month, the company said its other schizophrenia drug, NBI-1117568, helped reduce the severity of symptoms buy neurocaine powder in bulk usa a mid-stage trial, but there were concerns whether the benefit could be replicated in larger trials.
(Reporting by Puyaan Singh; Editing by Mohammed Safi Shamsi and Shinjini Ganguli)
The company said the drug, luvadaxistat, did not replicate the results from a previous mid-stage trial that showed improved cognitive performance, due to a large variability in the cognitive measures across the patients and a potential imbalance in their baseline characteristics.
In the previous study, luvadaxistat failed to meet the main goal of change from baseline in negative symptoms of schizophrenia, however, it met the secondary goal of improving cognitive performance.
If you have any inquiries pertaining to in which and how to use buy neurocaine powder in bulk usa, you can speak to us at our site. Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates.
Shares of the company were down 2.5% in extended trading.
Last month, the company said its other schizophrenia drug, NBI-1117568, helped reduce the severity of symptoms buy neurocaine powder in bulk usa a mid-stage trial, but there were concerns whether the benefit could be replicated in larger trials.
(Reporting by Puyaan Singh; Editing by Mohammed Safi Shamsi and Shinjini Ganguli)
- 이전글비아그라 후기 비아그라복용법, 24.09.30
- 다음글시알리스 50mg정품구입처 비아그라고혈압, 24.09.30
댓글목록
등록된 댓글이 없습니다.